|
PHACTR4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2205791932729E-12 |
| Normal-vs-Stage2 |
8.01020000329444E-08 |
| Normal-vs-Stage3 |
2.99760216648792E-14 |
| Normal-vs-Stage4 |
1.62492241884138E-12 |
| Stage1-vs-Stage2 |
9.324600E-01 |
| Stage1-vs-Stage3 |
1.347560E-02 |
| Stage1-vs-Stage4 |
1.042180E-03 |
| Stage2-vs-Stage3 |
9.188000E-02 |
| Stage2-vs-Stage4 |
7.036200E-03 |
| Stage3-vs-Stage4 |
1.879650E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
7.91709999781176E-08 |
| Normal-vs-Asian |
7.32859994911905E-09 |
| Caucasian-vs-AfricanAmerican |
9.881200E-01 |
| Caucasian-vs-Asian |
4.400000E-01 |
| AfricanAmerican-vs-Asian |
5.719400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.84610035328603E-10 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.138200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.72568683973896E-12 |
| Normal-vs-Age(41-60Yrs) |
1.07580611086178E-13 |
| Normal-vs-Age(61-80Yrs) |
1.67488245494951E-12 |
| Normal-vs-Age(81-100Yrs) |
9.97259999999667E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.852790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.511900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.513200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.943000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.658800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.599400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.840970E-03 |
| Classical-VS-Follicular |
5.628400E-01 |
| Classical-VS-Other |
7.943800E-01 |
| Classical-VS-Normal |
1.62836411021772E-12 |
| Tall-VS-Follicular |
1.241190E-03 |
| Tall-VS-Other |
2.517200E-01 |
| Tall-VS-Normal |
1.92212912253353E-12 |
| Follicular-VS-Other |
8.680600E-01 |
| Follicular-VS-Normal |
2.84240000425484E-08 |
| Other-VS-Normal |
1.164390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.27708995892817E-12 |
| Normal-vs-N1 |
9.17044218340379E-14 |
| N0-vs-N1 |
3.264000E-02 |
|
|
